Over the past several years, numerous targeted therapies have been approved for advanced non-small cell lung cancer (NSCLC), providing more options for eligible patients and further highlighting the importance of biomarker testing. Additionally, with recent approvals in the adjuvant setting, there is now a role for certain biomarker testing in early-stage NSCLC. As the therapeutic landscape for NSCLC continues to rapidly evolve, healthcare professionals must remain up to date on testing recommendations and treatment options for patients with NSCLC, including those with actionable biomarkers. In this video lecture, an expert discusses the importance of comprehensive biomarker testing in NSCLC, methods of testing, who and when to test, and available targeted therapies for those with identified actionable biomarkers.
After completing this activity, participants should be better able to:
- Identify actionable biomarkers in NSCLC
- Describe guideline-recommended testing strategies for NSCLC
- Develop treatment strategies based on actionable biomarkers in patients with NSCLC
Oncology NPs, PAs, and nurses
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
Nursing contact hours: 1.00, which includes 1.00 hours of pharmacology credit
NP course advisors: Beth Sandy, MSN, CRNP, Abramson Cancer Center, Philadelphia, Pennsylvania; Rasheda Persinger, MSN, AGNP-C, AOCNP, Johns Hopkins University, Washington, DC
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until August 14, 2023. PAs should only claim credit commensurate with the extent of their participation.
PA course advisor: Jessica Garner, DMSc, PA-C, University of the Pacific, Sacramento, California
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credits for learning and change.
This program was cosupported by educational grants from: AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo, Inc; Genentech, a member of the Roche Group; GlaxoSmithKline; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Lilly; Merck Sharp & Dohme Corp.; Regeneron Pharmaceuticals, Inc and Sanofi; and Seagen Inc. and Astellas.
This activity is supported by an educational grant from: Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Rasheda Persinger, MSN, AGNP-C, AOCNP: consultant/advisor/speaker: AstraZeneca, Guardiant Health, Pfizer.
Beth Sandy, MSN, CRNP: consultant/advisor/speaker: Amgen, AstraZeneca, Janssen, Jazz, Merck, Takeda.
None of the members of the Planning Committee or PCE staff have any relevant financial relationships to disclose, except Beth Sandy, MSN, CRNP, and Rasheda Persinger, MSN, AGNP-C, AOCNP as noted above.
Participants wishing to earn CE/CME credit must:
- View the content in its entirety
- Relate the content material to the learning objectives
- Complete evaluation form
The estimated time to complete this activity is 1.00 hour.
Release date: August 15, 2022
Expiration date: August 14, 2023
© 2022 Practicing Clinicians Exchange. All Rights Reserved. 104922O-7E